Besides providing an essential contribution to the growth of melanoma cells, the melanocortin type 1 receptor (MC1-R)—also named melanocyte-stimulating hormone receptor (MSHR)—is abundantly expressed on the surface of melanin positive primary MM and related metastatic lesions [2]. Here, MC1R is linked to Miyoshi myopathy.